Literature DB >> 4624553

The catabolism of human G immunoglobulins of different heavy chain subclasses. 3. The catabolism of heavy chain disease proteins and of Fc fragments of myeloma proteins.

H L Spiegelberg, B G Fishkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4624553      PMCID： PMC1713114     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  20 in total

1.  Heavy-chain subclasses of human gamma-G-globulin. Peptide and immunochemical relationships.

Authors:  H M Grey; H G Kunkel
Journal:  Biochemistry       Date:  1967-08       Impact factor: 3.162

2.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

3.  Biologic activities of aggregated gamma-globulin. 8. Aggregated immunoglobulins of different classes.

Authors:  T Ishizaka; K Ishizaka; S Salmon; H Fudenberg
Journal:  J Immunol       Date:  1967-07       Impact factor: 5.422

4.  N- and C-terminal sequences of a heavy chain disease protein and its genetic implications.

Authors:  J W Prahl
Journal:  Nature       Date:  1967-09-23       Impact factor: 49.962

5.  Catabolism of human gamma-G immunoglobulins of different heavy chain subclasses. II. Catabolism of gamma-G myeloma proteins in heterologous species.

Authors:  H L Spiegelberg; H M Grey
Journal:  J Immunol       Date:  1968-10       Impact factor: 5.422

6.  The production of antisera to human gammaGlobulin subclasses in rabbits using immunological unresponsiveness.

Authors:  H L Spiegelberg; W O Weigle
Journal:  J Immunol       Date:  1968-08       Impact factor: 5.422

7.  Biosynthetic and structural studies of a heavy chain disease protein.

Authors:  D Ein; D N Buell; J L Fahey
Journal:  J Clin Invest       Date:  1969-04       Impact factor: 14.808

8.  Skin-sensitizing activity related to gamma- polypeptide chain characteristics of human IgG.

Authors:  W D Terry
Journal:  J Immunol       Date:  1965-12       Impact factor: 5.422

9.  Studies on the catabolism of gamma- G subunits and chains.

Authors:  H L Spiegelberg; W O Weigle
Journal:  J Immunol       Date:  1965-12       Impact factor: 5.422

10.  Catabolism of human gammaG-immunoglobulins of different heavy chain subclasses. I. Catabolism of gammaG-myeloma proteins in man.

Authors:  H L Spiegelberg; B G Fishkin; H M Grey
Journal:  J Clin Invest       Date:  1968-10       Impact factor: 14.808
View more
  13 in total

1.  Serum disappearance and catabolism of homologous immunoglobulin fragments in rats.

Authors:  W P Arend; F J Silverblatt
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

Review 2.  Pharmacokinetics of recombinant bifunctional fusion proteins.

Authors:  Xiaoying Chen; Jennica L Zaro; Wei-Chiang Shen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-03-20       Impact factor: 4.481

3.  Catabolism of homologous murine monoclonal hybridoma IgG antibodies in mice.

Authors:  P J Talbot; M J Buchmeier
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

4.  Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor.

Authors:  Jaspreet Singh Jaggi; Jorge A Carrasquillo; Surya V Seshan; Pat Zanzonico; Erik Henke; Andrew Nagel; Jazmin Schwartz; Brad Beattie; Barry J Kappel; Debjit Chattopadhyay; Jing Xiao; George Sgouros; Steven M Larson; David A Scheinberg
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

5.  Human myeloma IgG half-molecules. Catabolism and biological properties.

Authors:  H L Spiegelberg
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

6.  Human myeloma IgA half-molecules.

Authors:  H L Spiegelberg; B G Fishkin
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

7.  Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.

Authors:  Mark T Albrecht; Han Li; E Diane Williamson; Chris S LeButt; Helen C Flick-Smith; Conrad P Quinn; Hans Westra; Darrell Galloway; Alfred Mateczun; Stanley Goldman; Herman Groen; Les W J Baillie
Journal:  Infect Immun       Date:  2007-07-23       Impact factor: 3.441

Review 8.  Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics.

Authors:  Kine Marita Knudsen Sand; Malin Bern; Jeannette Nilsen; Hanna Theodora Noordzij; Inger Sandlie; Jan Terje Andersen
Journal:  Front Immunol       Date:  2015-01-26       Impact factor: 7.561

9.  A human endothelial cell-based recycling assay for screening of FcRn targeted molecules.

Authors:  Algirdas Grevys; Jeannette Nilsen; Kine M K Sand; Muluneh B Daba; Inger Øynebråten; Malin Bern; Martin B McAdam; Stian Foss; Tilman Schlothauer; Terje E Michaelsen; Gregory J Christianson; Derry C Roopenian; Richard S Blumberg; Inger Sandlie; Jan Terje Andersen
Journal:  Nat Commun       Date:  2018-02-12       Impact factor: 14.919

Review 10.  Human plasma protein N-glycosylation.

Authors:  Florent Clerc; Karli R Reiding; Bas C Jansen; Guinevere S M Kammeijer; Albert Bondt; Manfred Wuhrer
Journal:  Glycoconj J       Date:  2015-11-10       Impact factor: 2.916
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.